Why so many people reach for the injection before the operation, what the long-term evidence says, and how the two paths actually fit together.
A decade ago, the path through serious weight management was relatively settled. You tried lifestyle change. If that was not enough and your situation was serious, surgery was the proven next step. Today the order has been scrambled. A new generation of weight management medication has arrived, and for a growing number of people it is now the first, and sometimes only, medical step they take. Surgery, long considered the most effective treatment we have, has quietly moved down the queue.
This shift is happening faster than the guidance can keep up, and much of it is being driven not by clinical advice but by patients themselves, reading, watching, and deciding. That makes one question more important than ever, and it is the question this guide is built around: if you are weighing up medication and surgery, which comes first, and who should help you decide?
Why the injection is winning the attention
It is worth being clear about why this class of medication has captured the conversation so completely. The appeal is real and rational, not just hype.
- It avoids an operation. For most people, a weekly injection is far less daunting than surgery that permanently alters the digestive system. No hospital stay, no recovery weeks, no operative risk.
- It feels reversible. Surgery is a one-way decision. Medication feels like something you can stop. (As we will see, that very feature is also its central limitation.)
- It carries less stigma. For many people a prescription feels more like treating any other chronic condition, and less weighty than the idea of an operation.
- It is everywhere. Public figures, social media, and constant news coverage have made these medications culturally visible in a way surgery never was. Familiarity breeds preference.
- It is easier to access. A consultation and a script is a lower barrier than a surgical referral pathway. Even so, as we will discuss, the financial cost over time can be the reverse of what people expect.
None of these reasons is wrong. The medication is a genuine advance, and for many people it is exactly the right first step. The problem is not that people are choosing it. It is that many are choosing it instead of a full conversation about the alternatives, rather than as part of one.
A measurable shift, and a quiet concern
The change is not anecdotal. In large studies of insured patients in the United States, prescriptions for this medication class surged while bariatric surgery rates fell sharply over the same period. One analysis of millions of patients reported a drop in surgery of around a third between 2022 and 2024, and national figures fell below 200,000 procedures for the first time in years. The medication did not simply add new patients. It appears to have substituted for surgery in many.
Here is the part that gives clinicians pause. Several analyses have found that the patients still proceeding to surgery were more medically complex, and there is concern, raised by these analyses, that some patients with the strongest long-term surgical evidence may now be defaulting to medication without surgery ever being properly put on the table for them.
A note on the Australian picture: these figures come from US health systems. Locally published data through recent years showed bariatric surgery still rising and concentrated heavily in the private sector. Whether Australia is seeing a similar medication-driven dip is not yet established in the same way. But given how global the medication trend is, it would be surprising if the pattern were not at least beginning here. We treat this as a likely emerging shift, not a settled local fact.
The long view: what happens over five to ten years
Most of the public conversation compares medication and surgery over months. The more revealing comparison is over years, and this is where the picture changes.
Surgery’s long-term record is well established. Patients who have a sleeve gastrectomy or gastric bypass typically lose around a quarter to a third of their body weight in the first year, and, importantly, are still maintaining weight loss in the order of 25% a full decade later, with some regain (often around 5%) being normal and expected. Beyond weight, long-term studies have linked surgery to lower rates of major cardiovascular events and reduced mortality over a ten-year horizon, alongside durable improvement in type 2 diabetes and blood pressure. This is decades of follow-up, including substantial Australian data.
The medication’s long-term record is genuinely thinner, for a simple reason. These drugs are comparatively new, so we do not yet have ten-year real-world weight data the way we do for surgery. What we do know is two-fold. First, in trials, average weight loss commonly reaches the high teens to low twenties as a percentage of body weight, impressive, though typically less than surgery. Second, and crucially, those results depend on staying on the medication. When people stop, weight tends to return in proportion to how much they lost, because the underlying biology is unchanged. And in the real world, a large share of people do stop within the first year, with cost, side effects, and lack of support all playing a role.
So the durability question is not really which works better in a trial. It is which result this person can actually sustain over the next decade of their life, and the answer differs from person to person.
The reasonable path many people now take, and where it leads
Given all of the above, the path most people are now taking is entirely reasonable: start with medication. It is less invasive, more familiar, and for a large number of people it produces meaningful results. For some, it will be the right long-term answer on its own.
And if you are one of the many people who started on medication and have since found yourself quietly wondering whether it is really the whole answer, perhaps because the results have plateaued, the cost is mounting, or you are uneasy about staying on it indefinitely, you are far from alone. That question is one of the most common experiences in weight management right now. It is not a sign you did something wrong. It is the natural next thought for thousands of people on exactly the same path, and it is worth taking seriously rather than pushing aside.
For some, medication becomes the beginning of a longer journey rather than the end of one. Several patterns are emerging in clinical practice:
- Medication first, surgery later. Some people lose weight on medication, then find they plateau, cannot tolerate it, cannot sustain the cost, or regain when they stop, and surgery becomes the durable next step. The medication was not a failure. It was a stage.
- Medication to prepare for surgery. Used before an operation, it can reduce weight and surgical risk, making the procedure safer.
- Medication after surgery. For patients who experience weight regain or suboptimal loss in the years following surgery, this medication class is increasingly used, typically well after recovery, to protect and extend the result.
The takeaway is not that one path is right and the other wrong. It is that medication and surgery are increasingly partners across a lifetime, not a single either/or choice made once.
The hard part: who is actually making the decision?
Here is the uncomfortable reality. The question of which path to take first is genuinely difficult. It depends on how much weight someone needs to lose, their metabolic health, their other conditions, their ability to sustain treatment, their finances, and their own preferences. It is exactly the kind of decision that should be made with clinical guidance.
Yet increasingly it is being made alone. Many people arrive at a firm decision, medication and only medication, before any in-depth clinical conversation, shaped largely by what they have read and seen. That is understandable, but it carries a quiet risk: the person who would genuinely be better served by surgery may never have it properly raised with them, and the person for whom medication is perfect may not have the support to actually sustain it.
Formal medical guidance does exist. Stepped-care frameworks reserve and recommend surgery for those who do not reach meaningful results by other means, and treat both tools as part of one pathway. The problem is that this guidance largely lives inside the profession. It is not what shapes the public conversation, and it does not reliably reach people at the moment they decide.
Where a GP or specialist should sit in this
This is precisely where a trusted clinical relationship earns its value. Whoever a person sees first, a GP, or a weight loss specialist they are referred to, is positioned to do the thing the internet cannot: look at the whole person and ask the questions that determine which path makes sense.
- How much weight, and how serious is the metabolic picture? The more severe the obesity and its complications, the stronger the case for considering surgery rather than ruling it out by default.
- Can this person sustain medication, practically and financially, for the long term? If not, a medication-only plan may quietly set them up for regain.
- Has surgery even been put on the table as a genuine option, or has it been quietly skipped over?
- What does the person actually want, once they understand the real trade-offs rather than the headline version?
The role is not to push anyone toward a particular door. It is to make sure all the doors are visible, the trade-offs are honest, and the decision is informed rather than inherited from a feed. For many patients, the ideal is a coordinated plan that may begin with one tool and keep the others genuinely on the table.
Medication vs surgery: an honest side-by-side
| This medication class | Bariatric (metabolic) surgery | |
|---|---|---|
| Typical weight loss | High teens to low twenties (%) in trials; often less in real life | Around 25 to 35% in year one |
| Durability | Depends on staying on it; regain common after stopping | Around 25% maintained at 10 years |
| Invasiveness | Weekly injection; no procedure | Keyhole surgery; recovery period |
| Long-term evidence | Still limited (newer treatment) | Decades, including Australian registry data |
| Cost over time | Ongoing monthly; adds up over years | Higher upfront; often lower long-term |
| Best thought of as | A treatment to stay on, like other chronic-disease medication | A durable reset, strongest for more severe obesity |
Read this as a map, not a scoreboard. Which option is better depends entirely on the person, their starting point, their health, and what they can sustain.
What needs to change, and who needs to change it
The deeper issue is not which single option is best. It is that the arrival of effective medication has quietly changed the whole pathway, and the way care is organised has not caught up. The response cannot sit with one part of the chain alone. A GP referring someone for medication, a prescriber writing the script, a specialist weight management service, and a bariatric surgeon are no longer separate doors a person picks between. They are points on a single pathway that a person may move along over years.
That requires everyone in the chain to think holistically. The person prescribing medication should be willing to raise surgery when it is the better long-term answer. The surgeon should recognise where medication has a role before or after an operation. And the service a person engages with, whatever its starting point, should treat medication as one tool among several rather than the only one on offer.
This is the change Anova exists to push for. We are not arguing that we are the only step in the pathway, or even that we are always the right one. We are arguing that the pathway itself has to become more joined-up, and that whoever a person sees first owes them a genuine look at all the options, not just the one in front of them. The goal is simple: that no one ends up on the wrong path first simply because the right one was never properly put in front of them.
A note on this topic: the right path is a clinical decision made with qualified professionals who know your full history. This article is general information, not medical advice, and does not recommend any specific medication or procedure for any individual.